← FDA Drug Approvals (Drugs@FDA)

EXELON

NDA · New Drug Application · Sponsor: SANDOZ · Approved 2007-07-06

Drug application

FDA Application #

NDA022083

Application type

New Drug Application

Brand name

EXELON

Generic name

RIVASTIGMINE

Active ingredients

RIVASTIGMINE

Dosage form

FILM, EXTENDED RELEASE

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2007-07-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown